VERTEX PHARMACEUTIC (VX1 BE) stock market data APIs
€356.2323
0(0%)
as of November 4, 2025
Try our APIs with
free plan!
VERTEX PHARMACEUTIC Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for VX1.BE.
Prev. Close
356.2323
Open
356.2323
High
356.2323
Low
356.2323
52 wk Range
312.45-482
Market Cap
46 841 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get VERTEX PHARMACEUTIC data using free add-ons & libraries
Get VERTEX PHARMACEUTIC Fundamental Data
VERTEX PHARMACEUTIC Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-03
- EPS/Forecast: 4.58
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
VERTEX PHARMACEUTIC News
New
McDonald’s Earnings, Tariff Update, Musk Pay Vote: What to Watch This Week
Following President Trump's return from Asia, eyes are on whether an end to the government shutdown is in sight. Meanwhile, investors will dig into earnings from McDonald’s, Palantir and a host of other companies. Continue Reading View Comments
Vertex Pharmaceuticals (VRTX): Exploring Valuation After Promising Kidney Therapy Results and Growth in New Treatments
Vertex Pharmaceuticals (VRTX) is gaining attention as new clinical data for its kidney disease therapy, povetacicept, shows encouraging results. The company’s portfolio is also benefiting from stead...
Palantir, AMD, Pfizer, Robinhood, McDonald’s, and Many More Stocks to Watch This Week
Vertex, Corteva, and many more will also report earnings. On the economic front, The Supreme Court will hear arguments on the legality of Trump’s tariffs, and ADP will release October employment data. Continue Reading View Comments
Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week
After one of the busiest weeks of the year, another jam-packed week awaits investors, with a rush of corporate earnings slated for the first week of November, as just over eight weeks remain in 2025. ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
